TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor.

Irene Y Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.